|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.060 USD | -1.94% |
|
-5.77% | -27.19% |
| 06-12 | Alembic Pharma Gets Final NoD From USFDA for Tretinoin Cream | MT |
| 06-01 | Bausch + Lomb Launching Triple Care Preservative Free Lubricant Eye Drops in the United States | MT |
| Market Cap | 1.89B 1.63B 1.5B 1.41B 2.64B 180B 2.68B 17.76B 6.92B 87.43B 7.09B 6.94B 303B | P/E Ratio 2026 * |
-11.4x | P/E Ratio 2027 * | 3.07x |
|---|---|---|---|---|---|
| Enterprise Value | 20.29B 17.53B 16.15B 15.12B 28.33B 1,929B 28.77B 191B 74.35B 939B 76.15B 74.53B 3,250B | EV / Sales 2026 * |
1.89x | EV / Sales 2027 * | 1.77x |
| Free-Float |
87.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bausch Health Companies Inc.
| 1 day | -1.94% | ||
| 1 week | -5.77% | ||
| Current month | -5.60% | ||
| 1 month | -4.35% | ||
| 3 months | +2.02% | ||
| 6 months | -26.88% | ||
| Current year | -27.19% |
| 1 week | 5.04 |  | 5.39 |
| 1 month | 4.94 | | 5.61 |
| Current year | 4.93 | | 8 |
| 1 year | 4.93 | | 8.68 |
| 3 years | 3.96 | | 11.46 |
| 5 years | 3.96 | | 31.59 |
| 10 years | 3.96 | | 34.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 64 | 2022-05-09 |
| Director of Finance/CFO | 60 | 2024-08-18 | |
Jonathan Sadeh
CTO | Chief Tech/Sci/R&D Officer | - | 2024-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Power
CHM | Chairman | 69 | 2022-05-09 |
Thomas Appio
BRD | Director/Board Member | 64 | 2022-05-09 |
Amy Wechsler
BRD | Director/Board Member | 56 | 2016-06-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-21 | Free | Director | 45,871 | 0.0123% | ||
| 05-21 | Free | Director | 45,871 | 0.0123% | ||
| 05-21 | Option | Director | 45,871 | 0.0123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.94% | -5.77% | -15.38% | -32.08% | 1.89B | |
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | |
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | |
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | |
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | |
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | |
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | |
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | |
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | |
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | |
| Average | +0.02% | +0.18% | +15.50% | +37.64% | 343.08B | |
| Weighted average by Cap. | -0.23% | +1.03% | +27.74% | +70.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.75B 9.28B 8.55B 8.01B 15B 1,021B 15.23B 101B 39.37B 497B 40.33B 39.47B 1,721B | 10.74B 9.28B 8.55B 8B 15B 1,021B 15.23B 101B 39.35B 497B 40.31B 39.45B 1,720B |
| Net income | -163M -141M -130M -121M -228M -15.49B -231M -1.53B -597M -7.54B -612M -599M -26.11B | 620M 536M 494M 462M 866M 58.98B 880M 5.83B 2.27B 28.71B 2.33B 2.28B 99.4B |
| Net Debt | 18.4B 15.89B 14.65B 13.71B 25.69B 1,749B 26.09B 173B 67.42B 851B 69.06B 67.59B 2,948B | 17.1B 14.77B 13.61B 12.74B 23.88B 1,626B 24.25B 161B 62.67B 791B 64.19B 62.82B 2,740B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 5.060 $ | -1.94% | 1,853,529 |
| 26-06-11 | 5.160 $ | +0.19% | 1,441,217 |
| 26-06-10 | 5.150 $ | -0.39% | 1,933,467 |
| 26-06-09 | 5.170 $ | +1.17% | 1,807,485 |
| 26-06-08 | 5.110 $ | -4.84% | 1,855,383 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition